PODCAST
Pharma Market Access Insights - from Petauri Evidence
We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence.
All Episodes
31:25
The Evolving NHS – An ICS Chief Pharmacist’s Perspective
en-us
44:31
First to Market: Unlocking Switzerland’s Pharma...
en-us
60:10
Q&A Webinar: The Evolving NHS Landscape in England –...
en-us
52:41
Global Pricing and Market Access – Strategies for...
en-us
33:52
Transforming Global Market Access: Smarter Resource...
en-us
59:02
Communicating value to US Payers: Insights for Pharma...
en-us
44:41
Navigating market access: Launch strategies and...
en-us
57:34
Navigating US payer evidence needs to optimise market...
en-us
59:53
Best practice RWE approaches to support economic...
en-us
62:50
NHS winter planning 2024–25 – Engaging with NHS...
en-us
56:15
De-mystifying the NHS – What you need to know about...
en-us
62:14
NHS primary care panel – the GP Contract and...
en-us
20:55
Engage NHS healthcare decision-makers with RWD
en-us
47:43
Market access and reimbursement in Canada – changes...
en-us
59:10
Rare Disease market access in the MENA and Nordic...
en-us
60:15
How does funding flow in NHSE Regions?
en-us
62:06
NHS policy for 2024/25: strategy and engagement in a...
en-us
60:28
De-mystifying health economic model classifications...
en-us
53:24
Evidence strategy for Medical Technologies and...
en-us
43:06
How to set your Pharma or Medtech product up for...
en-us